Professor<\/p>\n
Christian Medical College<\/p>\n
India<\/p>\n","protected":false},"excerpt":{"rendered":"
Alok Srivastava, MD, FRACP, FRCPA, FRCP Christian Medical College, Vellore, India Alok Srivastava is a Professor of Medicine in the Department of Haematology, and head of the Centre for Stem Cell Research at the Christian Medical College (CMC), Vellore in India. Dr. Srivastava has been involved with the management of patients with bleeding disorders for over 25 years. His group has worked extensively on developing genetic diagnosis of bleeding disorders and clinical protocols for their management including outcomes assessment which address the needs in developing countries particularly the use of lower dose prophylaxis as an alternative to episodic factor replacement therapy. A major focus of his group’s current research include assessment of novel therapies in different clinical trials as well as developing gene therapy for hemophilia using both AAV and lentiviral approaches. He leads the World Federation of Hemophilia designated International Hemophilia Training Center at CMC, Vellore. Dr. Srivastava is President of the Indian Association for Haemophilia & Allied Disorders. He is also the chair of the steering committee of the Association for Haemophilia & Allied Disorders \u2013 Asia-Pacific. He was the chair of the FVIII\/IX subcommittee of the Scientific and Standardization Committee (SSC), International Society of Thrombosis and Haemostasis (ISTH) from 2006-2010. He was on the board of the WFH from 2002-2014 and served as the Vice-President (Medical) from 2012-2014. He has led the writing group for all three editions of the WFH guidelines for the management of hemophilia. <\/p>\n","protected":false},"featured_media":73319,"template":"","meta":{"inline_featured_image":false},"speaker-type":[268,270],"class_list":["post-73360","speaker","type-speaker","status-publish","has-post-thumbnail","hentry","speaker-type-all-speakers-es","speaker-type-speakers-es"],"yoast_head":"\n